Detalhe da pesquisa
1.
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.
Blood
; 141(10): 1159-1168, 2023 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150143
2.
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
Br J Haematol
; 204(3): 849-860, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996986
3.
Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results.
Haematologica
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38841789
4.
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Hematol Oncol
; 42(3): e3272, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38595316
5.
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601.
Ann Hematol
; 103(6): 2021-2031, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38280061
6.
Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.
Proc Natl Acad Sci U S A
; 118(11)2021 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649182
7.
Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.
Cancer Sci
; 114(8): 3461-3465, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232264
8.
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.
Haematologica
; 108(3): 811-821, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200417
9.
[Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma].
Rinsho Ketsueki
; 64(4): 271-276, 2023.
Artigo
em Japonês
| MEDLINE | ID: mdl-37121771
10.
Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia/lymphoma: Phase IIb results.
Cancer Sci
; 113(8): 2778-2787, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579212
11.
Diagnostic utility of the aberrant immunohistochemical expression of CD3 molecules for peripheral T-cell lymphomas.
Ann Diagn Pathol
; 60: 152013, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35905535
12.
Epidemiology of adult T-cell leukemia-lymphoma in Japan: An updated analysis, 2012-2013.
Cancer Sci
; 112(10): 4346-4354, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355480
13.
HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1).
Cancer Sci
; 112(12): 5011-5019, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34626515
14.
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).
Br J Haematol
; 192(3): 531-541, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583431
15.
Comparison of the International Workshop Criteria and the Response Evaluation Criteria in Solid Tumors for indolent B-cell lymphoma.
Int J Clin Oncol
; 26(2): 429-437, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33111205
16.
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(4): 593-602, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171071
17.
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
Cancer Sci
; 111(12): 4567-4580, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32976684
18.
R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study.
Cancer Sci
; 111(10): 3770-3779, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767806
19.
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Lancet
; 393(10168): 229-240, 2019 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522922
20.
Possibility of a risk-adapted treatment strategy for untreated aggressive adult T-cell leukaemia-lymphoma (ATL) based on the ATL prognostic index: a supplementary analysis of the JCOG9801.
Br J Haematol
; 186(3): 440-447, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31099033